Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Glioma 1Glioblastoma 1Breast Neoplasms 1

Interventions

pembrolizumab 17Carboplatin 13Paclitaxel 12Cisplatin 12Radiation 10Doxorubicin 10Cyclophosphamide 9Radiotherapy 8Vincristine 7Nivolumab 7Metformin 7Etoposide 7Cytarabine 7Radiotherapy, Intensity-Modulated 6Magnetic Resonance Spectroscopy 6Leucovorin 6Injections 6Fluorouracil 6tislelizumab 5Prednisone 5Pemetrexed 5Methotrexate 5Ipilimumab 5Cetuximab 5Bevacizumab 5fludarabine 4durvalumab 4atezolizumab 4Specimen Handling 4Radiotherapy, Conformal 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × 4-amino-4'-hydroxylaminodiphenylsulfone × 30 days × Clear all
NCT03975959 2026-06-04

PROMESSE

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Completed
426 enrolled
BreastCNS

Breast Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡